Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Top 3 Undervalued Small Caps With Insider Action In US For November 2024

In This Article:

Over the last 7 days, the United States market has risen by 5.7%, contributing to a substantial climb of 37% over the past year, with earnings forecasted to grow by 16% annually. In this robust market environment, identifying small-cap stocks with insider action can be an intriguing approach for investors looking to uncover potential opportunities.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name

PE

PS

Discount to Fair Value

Value Rating

Thryv Holdings

NA

0.7x

47.74%

★★★★★☆

HighPeak Energy

10.8x

1.6x

37.99%

★★★★★☆

Solo Brands

NA

0.2x

32.36%

★★★★★☆

Hanover Bancorp

10.8x

2.3x

43.02%

★★★★☆☆

Franklin Financial Services

10.2x

2.0x

32.84%

★★★★☆☆

USCB Financial Holdings

19.5x

5.6x

44.93%

★★★☆☆☆

First United

14.0x

3.2x

45.68%

★★★☆☆☆

Orion Group Holdings

NA

0.4x

-228.49%

★★★☆☆☆

Community West Bancshares

18.7x

2.9x

42.25%

★★★☆☆☆

Delek US Holdings

NA

0.1x

-69.24%

★★★☆☆☆

Click here to see the full list of 43 stocks from our Undervalued US Small Caps With Insider Buying screener.

Below we spotlight a couple of our favorites from our exclusive screener.

LifeMD

Simply Wall St Value Rating: ★★★★★★

Overview: LifeMD is a company that operates in the telehealth sector and also offers services through its Worksimpli segment, with a combined market capitalization of approximately $0.05 billion.

Operations: LifeMD generates revenue primarily from its Telehealth and Worksimpli segments, contributing $139.81 million and $53.25 million respectively. The company has seen a notable trend in its gross profit margin, reaching 89.64% as of September 2024. Operating expenses, including significant sales and marketing costs, impact the net income figures negatively despite high gross margins.

PE: -12.0x

LifeMD, a small company in the U.S., reported significant revenue growth to US$53.39 million for Q3 2024, up from US$38.61 million the previous year, despite remaining unprofitable with a net loss of US$5.13 million. Recent insider confidence is reflected in share purchases over the past year, suggesting potential value recognition by insiders. The launch of an integrated pharmacy enhances its telehealth platform and aims for annualized savings of about US$5 million, positioning LifeMD for future operational improvements and expansion opportunities within its sector.

NasdaqGM:LFMD Share price vs Value as at Nov 2024
NasdaqGM:LFMD Share price vs Value as at Nov 2024

Mid Penn Bancorp

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Mid Penn Bancorp operates as a full-service commercial banking and trust business with a market cap of approximately $0.33 billion.